يعرض 71 - 80 نتائج من 485 نتيجة بحث عن '"Emile E. Voest"', وقت الاستعلام: 1.34s تنقيح النتائج
  1. 71

    المساهمون: Surgery, CCA - Cancer Treatment and quality of life

    المصدر: Nature Biotechnology
    Nature Biotechnology. Nature Publishing Group
    Cattaneo, C M, Battaglia, T, Urbanus, J, Moravec, Z, Voogd, R, de Groot, R, Hartemink, K J, Haanen, J B A G, Voest, E E, Schumacher, T N & Scheper, W 2023, ' Identification of patient-specific CD4+ and CD8+ T cell neoantigens through HLA-unbiased genetic screens ', Nature Biotechnology, vol. 41, no. 6, pp. 783-787 . https://doi.org/10.1038/s41587-022-01547-0Test

  2. 72
  3. 73
  4. 74
  5. 75
  6. 76
  7. 77
  8. 78
  9. 79

    المساهمون: Hubrecht Institute for Developmental Biology and Stem Cell Research, Radiology and Nuclear Medicine, Graduate School, APH - Methodology, APH - Personalized Medicine, AII - Cancer immunology, CCA - Cancer biology and immunology

    المصدر: Clinical Cancer Research, 28(5), 960-971. American Association for Cancer Research Inc.
    Clinical Cancer Research, 28(5), 960-971. AMER ASSOC CANCER RESEARCH
    Clinical cancer research, 28(5), 960-971. American Association for Cancer Research Inc.

    وصف الملف: application/pdf

  10. 80

    المساهمون: Medical Oncology, Internal medicine, AII - Cancer immunology, CCA - Cancer Treatment and quality of life

    المصدر: Zeverijn, L J, van Waalwijk van Doorn-Khosrovani, S B, van Roy, A A M G P, Timmers, L, Ly Tran, T H, de Boer, J E, de Wit, G F, Geurts, B S, Gelderblom, H, Verheul, H M W, Blijlevens, N, Wymenga, A N M, Eskens, F A L M, Smit, E F, Bloemendal, H J & Voest, E E 2022, ' Harmonising patient-access programmes : the Dutch DRUG Access Protocol platform ', The Lancet Oncology, vol. 23, no. 2, pp. 198-201 . https://doi.org/10.1016/S1470-2045Test(21)00707-5
    The Lancet Oncology, 23(2), 198-201. Lancet Publishing Group
    Lancet Oncology, 23, 198-201
    Lancet Oncology, 23, 2, pp. 198-201